A 90‐day preclinical toxicological evaluation in rats of a highly purified and concentrated mulberry leaf extract

Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of applied toxicology Ročník 44; číslo 10; s. 1504 - 1517
Hlavní autoři: Murbach, Timothy S., Glávits, Róbert, Endres, John R., Hirka, Gábor, Pasics Szakonyiné, Ilona
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Wiley Subscription Services, Inc 01.10.2024
Témata:
ISSN:0260-437X, 1099-1263, 1099-1263
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1‐deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D‐glucose. This extract has previously been evaluated in acute and subacute (28‐day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90‐day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle‐control group. The no‐observed‐adverse‐effect‐level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets. In recent times, extracts of mulberry leaves, which have long been consumed as food, have gained popularity. We have conducted a 90‐day oral toxicity study in rats of a purified Morus alba leaf extract standardized to contain 5 ± 0.5% 1‐deoxynojirimycin to add to past acute and subacute toxicological evaluations. No adverse effects were observed, and no target organs were identified following administration of 0 (vehicle control), 850, 1700, and 2550 mg/kg bw/day. The NOAEL was determined as 2550 mg/kg bw/day.
AbstractList Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets.
Mulberry (genus Morus ) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non‐nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1‐deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D‐glucose. This extract has previously been evaluated in acute and subacute (28‐day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90‐day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle‐control group. The no‐observed‐adverse‐effect‐level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets. In recent times, extracts of mulberry leaves, which have long been consumed as food, have gained popularity. We have conducted a 90‐day oral toxicity study in rats of a purified Morus alba leaf extract standardized to contain 5 ± 0.5% 1‐deoxynojirimycin to add to past acute and subacute toxicological evaluations. No adverse effects were observed, and no target organs were identified following administration of 0 (vehicle control), 850, 1700, and 2550 mg/kg bw/day. The NOAEL was determined as 2550 mg/kg bw/day.
Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets.Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been introduced as a convenient way to consume mulberry for non-nutritional functional effects. Reducose® 5% is an Morus alba leaf extract that has been highly purified and standardized to a content of 5 ± 0.5% 1-deoxynojirimycin, a naturally present polyhydroxylated piperidine alkaloid analog of D-glucose. This extract has previously been evaluated in acute and subacute (28-day) oral toxicity studies in which no adverse effects of the test item were observed in mice or rats, respectively. Due to continued and growing interest in the extract in multinational markets, we have now further investigated potential toxic effects in subchronic (90-day) oral toxicity study in male and female Han:WIST rats. The test item was administered at doses of 850, 1700, and 2550 mg/kg bw/day, and did not cause adverse effects in clinical signs, body weight development, clinical pathology, gross pathology, or histopathology in comparison to the vehicle-control group. The no-observed-adverse-effect-level was determined to be 2550 mg/kg bw/day. These results add to the existing body of both preclinical and clinical work relevant to the safety of the extract and of interest to regulators in various global markets.
Author Hirka, Gábor
Pasics Szakonyiné, Ilona
Murbach, Timothy S.
Endres, John R.
Glávits, Róbert
Author_xml – sequence: 1
  givenname: Timothy S.
  orcidid: 0000-0002-7658-858X
  surname: Murbach
  fullname: Murbach, Timothy S.
  email: tim@aibmr.com
  organization: AIBMR Life Sciences, Inc
– sequence: 2
  givenname: Róbert
  surname: Glávits
  fullname: Glávits, Róbert
  organization: Toxi‐Coop Zrt
– sequence: 3
  givenname: John R.
  surname: Endres
  fullname: Endres, John R.
  organization: AIBMR Life Sciences, Inc
– sequence: 4
  givenname: Gábor
  surname: Hirka
  fullname: Hirka, Gábor
  organization: Toxi‐Coop Zrt
– sequence: 5
  givenname: Ilona
  surname: Pasics Szakonyiné
  fullname: Pasics Szakonyiné, Ilona
  organization: Toxi‐Coop Zrt
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38837228$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1qGzEUhUVJaZy0kCcIgmy6GVd_HmmWJvSXQDcpZCfuaKRERpYcaSaNd32EPmOfpIrzB6FdCV1951xxzgHaiylahI4omVNC2IcVjHPRCvEKzSjpuoaylu-hGWEtaQSXF_vooJQVIfWNqTdonyvFJWNqhsoSd-TPr98DbPEmWxN89AYCHtOtNymky93N3kCYYPQpYh9xhrHg5DDgK395Fapwyt55O2CIAzYpGhvHCtXBegq9zXmLgwWH7W0dm_Eteu0gFPvu4TxEPz59PD_90px9__z1dHnWGC460XSudcyIQTIA4wBE27e2l4IKxTjYjlK3UIIAp7QzRPYMFoNrASQ3zgGR_BC9v_fd5HQ92TLqtS_GhgDRpqloTtoFk5IJVdGTF-gqTTnW3-lqL8RCMUUqdfxATf3aDnqT_RryVj_G-bzR5FRKtu4JoUTfNaVrU_quqYrOX6DGj7uIa0Y-_EvQ3At--mC3_zXW35bnO_4v-9KlPQ
CitedBy_id crossref_primary_10_3390_molecules30153213
Cites_doi 10.1021/jf0306901
10.1097/MD.0000000000011996
10.1371/journal.pone.0152728
10.1016/j.jep.2016.09.004
10.1021/jf071559m
10.1093/bbb/zbac011
10.1021/jf062680g
10.1007/s40292-015-0087-2
10.1177/0192623312438736
10.1021/jf9022228
10.3389/fmed.2022.904339
10.1016/j.clnesp.2022.03.027
10.3358/shokueishi.44.191
10.3390/nu14132674
10.4103/0973-1296.80683
10.1089/jmf.2014.3160
10.1007/BF00401402
10.1155/2012/735191
10.1201/b13783-10
10.1007/BF02976442
10.1002/ptr.3270
10.1177/1091581816670597
10.1371/journal.pone.0172239
10.1016/j.ctim.2017.04.006
10.1021/jf010567e
10.1293/tox.27.1S
10.3746/jfn.2007.12.2.119
10.1186/s12986-021-00571-2
10.1080/09637480600801837
10.1371/journal.pone.0288911
10.1016/j.yrtph.2018.03.007
10.1155/2018/2091872
10.1016/j.ctim.2019.102292
10.1293/tox.26.27S
10.1111/j.2040-1124.2011.00101.x
ContentType Journal Article
Copyright 2024 John Wiley & Sons Ltd.
2024 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2024 John Wiley & Sons Ltd.
– notice: 2024 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7ST
7TK
7U7
C1K
K9.
SOI
7X8
DOI 10.1002/jat.4644
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Environment Abstracts
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
Environment Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Toxicology Abstracts
Neurosciences Abstracts
Environment Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1099-1263
EndPage 1517
ExternalDocumentID 38837228
10_1002_jat_4644
JAT4644
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Phynova Group Limited, Banbury UK and Nestle Health Science, Vevey Switzerland
– fundername: Phynova Group Limited, Banbury UK
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
EBD
EBS
EDH
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
GWYGA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
UB1
V8K
VH1
W8V
W99
WBFHL
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWP
WXSBR
WYISQ
XG1
XPP
XV2
YCJ
YHZ
ZXP
ZZTAW
~02
~IA
~KM
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
BANNL
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7ST
7TK
7U7
C1K
K9.
SOI
7X8
ID FETCH-LOGICAL-c3494-9f6f2c4d72aacfaa46b6eb7414823ae911f5840a3119c07b2a5df6aa73cffa073
IEDL.DBID DRFUL
ISICitedReferencesCount 1
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001336680400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0260-437X
1099-1263
IngestDate Sun Nov 09 13:31:34 EST 2025
Sat Nov 29 14:40:24 EST 2025
Thu Apr 03 07:03:45 EDT 2025
Sat Nov 29 07:06:50 EST 2025
Tue Nov 18 22:19:56 EST 2025
Wed Jan 22 17:16:04 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords toxicity
DNJ
90‐day study
NOAEL
mulberry leaf extract, MLE
1‐deoxynojirimycin
Reducose
Morus alba
OECD 408
Language English
License 2024 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3494-9f6f2c4d72aacfaa46b6eb7414823ae911f5840a3119c07b2a5df6aa73cffa073
Notes Ilona Pasics Szakonyiné
Senior Author
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7658-858X
PMID 38837228
PQID 3114458280
PQPubID 105373
PageCount 14
ParticipantIDs proquest_miscellaneous_3065277248
proquest_journals_3114458280
pubmed_primary_38837228
crossref_primary_10_1002_jat_4644
crossref_citationtrail_10_1002_jat_4644
wiley_primary_10_1002_jat_4644_JAT4644
PublicationCentury 2000
PublicationDate October 2024
2024-10-00
20241001
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: October 2024
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bognor Regis
PublicationSubtitle JAT
PublicationTitle Journal of applied toxicology
PublicationTitleAlternate J Appl Toxicol
PublicationYear 2024
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2013; 26
2013; 4
2012; 2012
2011; 2
2009; 20
2015; 18
2023; 18
2011
2006; 57
2014; 27
2009
1999; 22
2001; 49
2022; 86
2002
2024
2007; 55
2007; 12
2022; 49
2011; 7
2016; 35
1999
2016; 11
2004; 52
1968; 13
2009; 57
2012; 2
2018; 2018
2021; 18
2017; 32
2022; 9
2015; 22
2017; 12
2020; 49
2022; 14
2018
2018; 95
2014c
2014b
2011; 25
2013
2014a
2018; 97
2003; 44
2012; 40
2016; 194
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_47_1
Laddha G. (e_1_2_8_24_1) 2012; 2
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_5_1
e_1_2_8_4_1
Hard G. (e_1_2_8_13_1) 1999
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
e_1_2_8_44_1
Aditya Rao S. (e_1_2_8_3_1) 2013; 4
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
Abdulla M. (e_1_2_8_2_1) 2009; 20
e_1_2_8_18_1
e_1_2_8_39_1
FAO (e_1_2_8_10_1) 2002
e_1_2_8_19_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_32_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
Haschek W. (e_1_2_8_14_1) 2009
e_1_2_8_33_1
e_1_2_8_30_1
OECD (e_1_2_8_36_1) 2018
References_xml – volume: 18
  start-page: 306
  year: 2015
  end-page: 313
  article-title: Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: A randomized, double‐blind placebo‐controlled trial
  publication-title: Journal of Medicinal Food
– year: 2011
– volume: 12
  year: 2017
  article-title: Mulberry‐extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double‐blind placebo‐controlled study
  publication-title: PLoS ONE
– year: 2009
– volume: 55
  start-page: 5869
  year: 2007
  end-page: 5874
  article-title: Food‐grade mulberry powder enriched with 1‐deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans
  publication-title: Journal of Agricultural and Food Chemistry
– volume: 7
  start-page: 171
  year: 2011
  end-page: 175
  article-title: Evaluation of cytotoxicity and genotoxicity of some Philippine medicinal plants
  publication-title: Pharmacognosy Magazine
– volume: 44
  start-page: 191
  year: 2003
  end-page: 197
  article-title: Ninety‐day dietary toxicity study of mulberry leaf extract in rats [English translation]
  publication-title: Shokuhin Eiseigaku Zasshi
– start-page: 209
  year: 2013
  end-page: 254
– year: 2014c
– volume: 32
  start-page: 105
  year: 2017
  end-page: 108
  article-title: Impact of mulberry leaf extract on type 2 diabetes (Mul‐DM): A randomized, placebo‐controlled pilot study
  publication-title: Complementary Therapies in Medicine
– volume: 2018
  start-page: 1
  year: 2018
  end-page: 11
  article-title: A double‐blind placebo‐controlled randomized trial evaluating the effect of polyphenol‐rich herbal congee on bone turnover markers of the perimenopausal and menopausal women
  publication-title: Oxidative Medicine and Cellular Longevity
– volume: 35
  start-page: 683
  year: 2016
  end-page: 691
  article-title: A 28‐day repeated dose toxicological study of an aqueous extract of L
  publication-title: International Journal of Toxicology
– year: 2014a
– volume: 194
  start-page: 162
  year: 2016
  end-page: 168
  article-title: Evaluation of acute toxicity, genotoxicity and inhibitory effect on acute inflammation of an ethanol extract of L. (Moraceae) in mice
  publication-title: Journal of Ethnopharmacology
– year: 2024
– volume: 49
  year: 2020
  article-title: A randomized controlled study of dose‐finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes
  publication-title: Complementary Therapies in Medicine
– start-page: 1
  year: 1999
  end-page: 32
– volume: 20
  start-page: 35
  year: 2009
  end-page: 39
  article-title: Evaluation of the anti‐ulcer activities of extracts in experimentally‐induced gastric ulcer in rats
  publication-title: Biomedical Research
– volume: 13
  start-page: 222
  year: 1968
  end-page: 257
  article-title: Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse
  publication-title: Psychopharmacologia
– volume: 95
  start-page: 220
  year: 2018
  end-page: 226
  article-title: Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies
  publication-title: Regulatory Toxicology and Pharmacology
– volume: 18
  year: 2021
  article-title: Mulberry leaf extract improves glycaemic response and insulaemic response to sucrose in healthy subjects: Results of a randomized, double blind, placebo‐controlled study
  publication-title: Nutrition & Metabolism (London)
– volume: 57
  start-page: 305
  year: 2006
  end-page: 313
  article-title: Nutritional quality of leaves of some genotypes of mulberry ( )
  publication-title: International Journal of Food Sciences and Nutrition
– volume: 12
  start-page: 119
  year: 2007
  end-page: 121
  article-title: Tyrosinase inhibition and mutagenicity of phenolic compounds from mulberry leaves – research note
  publication-title: Preventive Nutrition and Food Science
– year: 2018
– volume: 11
  year: 2016
  article-title: Prevention effects and possible molecular mechanism of mulberry leaf extract and its formulation on rats with insulin‐insensitivity
  publication-title: PLoS ONE
– volume: 26
  start-page: 27S
  year: 2013
  end-page: 57S
  article-title: Proliferative and non‐proliferative lesions of the rat and mouse integument
  publication-title: Journal of Toxicologic Pathology
– volume: 4
  start-page: 822
  year: 2013
  end-page: 830
  article-title: Evaluation of anti‐inflammatory and analgesic activity in three species
  publication-title: Research Journal of Pharmaceutical, Biological and Chemical Sciences
– volume: 55
  start-page: 8928
  year: 2007
  end-page: 8933
  article-title: Occurrence of orally administered mulberry 1‐deoxynojirimycin in rat plasma
  publication-title: Journal of Agricultural and Food Chemistry
– volume: 25
  start-page: 365
  year: 2011
  end-page: 369
  article-title: Efficacy of mulberry leaf tablets in patients with mild dyslipidemia
  publication-title: Phytotherapy Research
– volume: 22
  start-page: 149
  year: 2015
  end-page: 154
  article-title: Effects of a new combination of nutraceuticals with on lipid profile, insulin sensitivity and endothelial function in dyslipidemic subjects. A cross‐over, randomized, double‐blind trial
  publication-title: High Blood Pressure & Cardiovascular Prevention
– volume: 86
  start-page: 519
  year: 2022
  end-page: 527
  article-title: Safety evaluation of a beverage containing mulberry leaf extract
  publication-title: Bioscience, Biotechnology, and Biochemistry
– volume: 22
  start-page: 81
  year: 1999
  end-page: 85
  article-title: Antioxidative flavonoids from the leaves of
  publication-title: Archives of Pharmacal Research
– volume: 49
  start-page: 68
  year: 2022
  end-page: 73
  article-title: Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: A double‐blind clinical trial
  publication-title: Clinical Nutrition ESPEN
– volume: 40
  start-page: 14S
  year: 2012
  end-page: 86S
  article-title: Proliferative and nonproliferative lesions of the rat and mouse urinary system
  publication-title: Toxicologic Pathology
– volume: 9
  year: 2022
  article-title: 13C‐sucrose breath test for the non‐invasive assessment of environmental enteropathy in Zambian adults
  publication-title: Frontiers in Medicine
– volume: 2
  start-page: 318
  year: 2011
  end-page: 323
  article-title: Effect of mulberry leaf extract with enriched 1‐deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism
  publication-title: Journal of Diabetes Investigation
– volume: 52
  start-page: 1415
  year: 2004
  end-page: 1418
  article-title: Determination of 1‐deoxynojirimycin in mulberry leaves using hydrophilic interaction chromatography with evaporative light scattering detection
  publication-title: Journal of Agricultural and Food Chemistry
– year: 2014b
– volume: 49
  start-page: 4208
  year: 2001
  end-page: 4213
  article-title: Polyhydroxylated alkaloids isolated from mulberry trees ( L.) and silkworms ( L.)
  publication-title: Journal of Agricultural and Food Chemistry
– year: 2002
– volume: 2
  start-page: 513
  year: 2012
  end-page: 519
  article-title: Anti‐psychotic effect of aqueous leaves extract of in animal models
  publication-title: International Journal of Pharmacy
– volume: 27
  start-page: 1S
  year: 2014
  end-page: 107S
  article-title: Nonproliferative and proliferative lesions of the rat and mouse female reproductive system
  publication-title: Journal of Toxicologic Pathology
– volume: 14
  year: 2022
  article-title: Effect of different nutritional supplements on glucose response of complete meals in two crossover studies
  publication-title: Nutrients
– volume: 2012
  year: 2012
  article-title: A six‐month supplementation of mulberry, Korean red ginseng, and banaba decreases biomarkers of systemic low‐grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes
  publication-title: Evidence‐Based Complementary and Alternative Medicine
– volume: 18
  year: 2023
  article-title: The impact of mulberry leaf extract at three different levels on reducing the glycemic index of white bread
  publication-title: PLoS ONE
– volume: 97
  year: 2018
  article-title: Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates
  publication-title: Medicine (Baltimore)
– volume: 57
  start-page: 9133
  year: 2009
  end-page: 9140
  article-title: Phytochemical profiles of different mulberry ( sp.) species from China
  publication-title: Journal of Agricultural and Food Chemistry
– ident: e_1_2_8_22_1
  doi: 10.1021/jf0306901
– ident: e_1_2_8_47_1
  doi: 10.1097/MD.0000000000011996
– ident: e_1_2_8_26_1
  doi: 10.1371/journal.pone.0152728
– ident: e_1_2_8_37_1
  doi: 10.1016/j.jep.2016.09.004
– ident: e_1_2_8_31_1
  doi: 10.1021/jf071559m
– ident: e_1_2_8_49_1
  doi: 10.1093/bbb/zbac011
– ident: e_1_2_8_21_1
  doi: 10.1021/jf062680g
– ident: e_1_2_8_45_1
  doi: 10.1007/s40292-015-0087-2
– ident: e_1_2_8_11_1
  doi: 10.1177/0192623312438736
– ident: e_1_2_8_40_1
  doi: 10.1021/jf9022228
– ident: e_1_2_8_39_1
  doi: 10.3389/fmed.2022.904339
– ident: e_1_2_8_42_1
  doi: 10.1016/j.clnesp.2022.03.027
– ident: e_1_2_8_30_1
  doi: 10.3358/shokueishi.44.191
– ident: e_1_2_8_12_1
  doi: 10.3390/nu14132674
– ident: e_1_2_8_33_1
– ident: e_1_2_8_7_1
  doi: 10.4103/0973-1296.80683
– ident: e_1_2_8_18_1
  doi: 10.1089/jmf.2014.3160
– ident: e_1_2_8_32_1
– volume-title: Mulberry for animal production: Proceedings of an electronic conference carried out between May and August 2000
  year: 2002
  ident: e_1_2_8_10_1
– volume-title: OECD guidelines for the testing of chemicals, section 4
  year: 2018
  ident: e_1_2_8_36_1
– ident: e_1_2_8_15_1
  doi: 10.1007/BF00401402
– ident: e_1_2_8_17_1
  doi: 10.1155/2012/735191
– ident: e_1_2_8_16_1
  doi: 10.1201/b13783-10
– ident: e_1_2_8_19_1
  doi: 10.1007/BF02976442
– ident: e_1_2_8_4_1
  doi: 10.1002/ptr.3270
– volume: 4
  start-page: 822
  year: 2013
  ident: e_1_2_8_3_1
  article-title: Evaluation of anti‐inflammatory and analgesic activity in three Morus species
  publication-title: Research Journal of Pharmaceutical, Biological and Chemical Sciences
– ident: e_1_2_8_28_1
  doi: 10.1177/1091581816670597
– ident: e_1_2_8_35_1
– ident: e_1_2_8_46_1
– volume: 20
  start-page: 35
  year: 2009
  ident: e_1_2_8_2_1
  article-title: Evaluation of the anti‐ulcer activities of Morus alba extracts in experimentally‐induced gastric ulcer in rats
  publication-title: Biomedical Research
– ident: e_1_2_8_27_1
  doi: 10.1371/journal.pone.0172239
– ident: e_1_2_8_38_1
  doi: 10.1016/j.ctim.2017.04.006
– ident: e_1_2_8_6_1
  doi: 10.1021/jf010567e
– ident: e_1_2_8_9_1
  doi: 10.1293/tox.27.1S
– ident: e_1_2_8_20_1
  doi: 10.3746/jfn.2007.12.2.119
– ident: e_1_2_8_44_1
  doi: 10.1186/s12986-021-00571-2
– ident: e_1_2_8_41_1
  doi: 10.1080/09637480600801837
– ident: e_1_2_8_23_1
– ident: e_1_2_8_8_1
  doi: 10.1371/journal.pone.0288911
– volume: 2
  start-page: 513
  year: 2012
  ident: e_1_2_8_24_1
  article-title: Anti‐psychotic effect of aqueous leaves extract of Morus alba in animal models
  publication-title: International Journal of Pharmacy
– ident: e_1_2_8_25_1
  doi: 10.1016/j.yrtph.2018.03.007
– volume-title: Gastrointestinal system: Diaphragmatic hernia, fundamentals of toxicologic pathology
  year: 2009
  ident: e_1_2_8_14_1
– ident: e_1_2_8_48_1
  doi: 10.1155/2018/2091872
– start-page: 1
  volume-title: Guides for toxicologic pathology
  year: 1999
  ident: e_1_2_8_13_1
– ident: e_1_2_8_43_1
  doi: 10.1016/j.ctim.2019.102292
– ident: e_1_2_8_29_1
  doi: 10.1293/tox.26.27S
– ident: e_1_2_8_5_1
  doi: 10.1111/j.2040-1124.2011.00101.x
– ident: e_1_2_8_34_1
SSID ssj0009928
Score 2.4048264
Snippet Mulberry (genus Morus) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been...
Mulberry (genus Morus ) leaves have long been used as a human food, especially in Asia, and animal feed. More recently, mulberry leaf extracts have been...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1504
SubjectTerms 1-Deoxynojirimycin - analogs & derivatives
1-Deoxynojirimycin - toxicity
1‐deoxynojirimycin
90‐day study
Administration, Oral
Animal feed
Animals
Body weight
Body Weight - drug effects
DNJ
Dose-Response Relationship, Drug
Feeds
Female
Global marketing
Histopathology
Leaves
Male
Morus - chemistry
Morus alba
mulberry leaf extract, MLE
No-Observed-Adverse-Effect Level
NOAEL
OECD 408
Organ Size - drug effects
Pathology
Piperidine
Plant extracts
Plant Extracts - toxicity
Plant Leaves - chemistry
Rats
Rats, Wistar
Reducose
Side effects
Toxicity
Toxicity testing
Toxicity Tests, Subchronic
Toxicology
Title A 90‐day preclinical toxicological evaluation in rats of a highly purified and concentrated mulberry leaf extract
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.4644
https://www.ncbi.nlm.nih.gov/pubmed/38837228
https://www.proquest.com/docview/3114458280
https://www.proquest.com/docview/3065277248
Volume 44
WOSCitedRecordID wos001336680400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1099-1263
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009928
  issn: 0260-437X
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JaxRBFH6YiQchuMQlozE8QcZLOulUVy91DOrgIYRBEplb87oWGBl7wvSMODd_gr_RX-KrXqYJKgie-lCvuoqqt3y1vK8AXhslhSiKODA24QVKkqhAZVIHUgnrwtiGSX0Z89NFenmZTadq0t6q9LkwDT_EdsPNW0btr72BU1Gd9qShn2l1Ijma78CuYLWNB7D77uP4-qKn3FX1y6qeNCuQUTrtqGdDcdrVvR2MfkOYtwFrHXHGD_6nrw_hfosz8bxRjEdwx5b7MJo0RNWbY7zq866qYxzhpKew3uzDXrObh02S0mOozlGFP7__MLTBG_aRbTolrhbfZrpzn9gzh-OsRFatChcOCT0l8pwrrpczx4gXqTSofbpkWVPjGvyy9kxbyw3OLTnkcOFTt57A9fj91dsPQftcQ6A9x02gXOKEliYVRNoRyaRIbMGIRWYiIste1THaCSk6O1M6TAtBsXEJURpp54hdzVMYlIvSHgCScqJgKMLRU0tbUGYoloV1RlsnY5sM4U03b7luucz9kxrzvGFhFjmPeO5HfAivtpI3DX_HH2QOu6nPWwuucu6lrM8UQ_7Ftphtzx-oUGkXa5Zh_CZ4eSKzITxrVGbbSJTx0l8ILhnVmvHX1nP2w_77_F8FX8A9wciquVF4CIPVcm1fwl39dTWrlkewk06zo9YWfgGoAQ7O
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bixMxFD6su4KCeFlXra56BKkvO-5sJnMJPi1qWbGWIl3p23Amk0ClTpdOK_bNn-Bv9Jd4MpcOiwqCT_OQk0lIzuXL5XwBeJ4rKUSWhV5uIl6gRJHyVCK1J5Uw1g-NH1WXMT8N49EomU7VeAdetbkwNT_EdsPNWUblr52Buw3p44419DOtXkoO51dgT7IWsXrvvfk4OB92nLuqelrVsWZ5MoinLfesL47bupej0W8Q8zJirULO4NZ_dfY23GyQJp7WqnEHdkyxD_1xTVW9OcJJl3lVHmEfxx2J9WYfbtT7eVinKd2F8hSV__P7j5w2eMFeskmoxNXi20y3DhQ77nCcFcjKVeLCIqEjRZ5zxfVyZhnzIhU5apcwWVTkuDl-WTuureUG54YscsBwyVsHcD54O3l95jUPNnjasdx4ykZWaJnHgkhbIhllkckYs8hEBGTYr1rGOz4FJydK-3EmKMxtRBQH2lpiZ3MPdotFYR4AkrIiYzDC8VNLk1GSUygzY3NtrAxN1IMX7cSlumEzd49qzNOah1mkPOKpG_EePNtKXtQMHn-QOWznPm1suEy5l7I6VfT5F9titj53pEKFWaxZhhGc4AWKTHpwv9aZbSNBwot_IbikX6nGX1tP2RO778N_FXwK184mH4bp8N3o_SO4Lhhn1fcLD2F3tVybx3BVf13NyuWTxiR-AWpoEdY
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bixMxFD6sXRFBvKy36qpHkPqy485mMpkJPi2uRbGUIrvStyGTC1TqtHRasW_-BH-jv8STuXRYVBB8mockk5Ccy5fL-Q7ACyM5Y3keB8YK2qAIIQOZch1wyawLYxuK6jHmp1EyHqfTqZzswes2Fqbmh9gduHnNqOy1V3C7NO64Yw39rNavOLnzK7DPfQ6ZHuyffRxejDrOXVmlVvWsWQGPkmnLPRuy47btZW_0G8S8jFgrlzO89V-DvQ03G6SJp7Vo3IE9WxzAYFJTVW-P8LyLvCqPcICTjsR6ewA36vM8rMOU7kJ5ijL8-f2HUVtckpVsAipxvfg2060BxY47HGcFknCVuHCo0JMiz6nhZjVzhHlRFQa1D5gsKnJcg182nmtrtcW5VQ7JYfjgrXtwMXx7_uZd0CRsCLRnuQmkE45pbhKmlHZKcZELmxNm4SmLlCW76gjvhCo6OZE6THKmYuOEUkmknVNkbO5Dr1gU9iGgko7lBEbIf2puc5UaFfPcOqOt47EVfXjZLlymGzZzn1RjntU8zCyjGc_8jPfh-a7msmbw-EOdw3bts0aHy4xGyatbxZB-sSsm7fNXKqqwiw3VIQTHaIPC0z48qGVm10mU0uafMSoZVKLx194zssT---hfKz6Da5OzYTZ6P_7wGK4zgln188JD6K1XG_sEruqv61m5etpoxC_dAhFR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+90-day+preclinical+toxicological+evaluation+in+rats+of+a+highly+purified+and+concentrated+mulberry+leaf+extract&rft.jtitle=Journal+of+applied+toxicology&rft.au=Murbach%2C+Timothy+S&rft.au=Gl%C3%A1vits%2C+R%C3%B3bert&rft.au=Endres%2C+John+R&rft.au=Hirka%2C+G%C3%A1bor&rft.date=2024-10-01&rft.issn=1099-1263&rft.eissn=1099-1263&rft.volume=44&rft.issue=10&rft.spage=1504&rft_id=info:doi/10.1002%2Fjat.4644&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0260-437X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0260-437X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0260-437X&client=summon